Immunomodulatory News and Research

RSS
TCM announces winners of 26th Annual Industry Awards

TCM announces winners of 26th Annual Industry Awards

Scientists find new way to predict response to platinum-based chemotherapy in women with triple-negative breast cancer

Scientists find new way to predict response to platinum-based chemotherapy in women with triple-negative breast cancer

FDA accepts Merck's MK-3475 BLA for review

FDA accepts Merck's MK-3475 BLA for review

Patrys reports final results from PAT-SM6 Phase I/IIa study in patients with refractory or relapsed MM

Patrys reports final results from PAT-SM6 Phase I/IIa study in patients with refractory or relapsed MM

Simvastatin may slow progression of multiple sclerosis

Simvastatin may slow progression of multiple sclerosis

Children newly diagnosed with Crohn's disease may benefit from biologic drugs

Children newly diagnosed with Crohn's disease may benefit from biologic drugs

Co-culture with mesenchymal stem cells results in improved viability, function of human hepatocytes

Co-culture with mesenchymal stem cells results in improved viability, function of human hepatocytes

Acetylon Pharmaceuticals presents positive interim data from two ricolinostat clinical trials at ASH 2013

Acetylon Pharmaceuticals presents positive interim data from two ricolinostat clinical trials at ASH 2013

UMass Medical School licenses "anti-gal" technology to Agalimmune

UMass Medical School licenses "anti-gal" technology to Agalimmune

Agalimmune established to develop innovative immunotherapeutics for treatment of cancer

Agalimmune established to develop innovative immunotherapeutics for treatment of cancer

immatics, Roche enter into cancer vaccine and immunotherapy deal

immatics, Roche enter into cancer vaccine and immunotherapy deal

Publication provides update on the origins and causes of anxiety disorders

Publication provides update on the origins and causes of anxiety disorders

Psoriasis and the nervous system: an interview with Dr Nicole Ward, Case Western Reserve University

Psoriasis and the nervous system: an interview with Dr Nicole Ward, Case Western Reserve University

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Preclinical study reveals pomalidomide shows promising results for treatment of CNS lymphoma

Preclinical study reveals pomalidomide shows promising results for treatment of CNS lymphoma

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

New drug for multiple myeloma could be available within next few months in Europe

New drug for multiple myeloma could be available within next few months in Europe

Researchers propose strategies for improving the anti-cancer effects of interferon

Researchers propose strategies for improving the anti-cancer effects of interferon

Immunotherapy and epigenetics advancements presented by Ludwig at the American Association for Cancer Research

Immunotherapy and epigenetics advancements presented by Ludwig at the American Association for Cancer Research

Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting

Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.